NF-KB signaling pathway-manipulated dendritic cells

US11466289B2 · kind B2 · utility

Inventors

• Katrin Birkholz · Erlangen, DE
• Jan Dörrie · Nuremberg, DE
• Niels Schaft · Herzogenaurach, DE
• Gerold Schuler · Spardorf, DE
• Reinhard Voll · Eggolsheim, DE
• Isabell Pfeiffer · Neustadt an der Aisch, DE

Key dates

• Filing date: Dec 4, 2017
• Grant date: Oct 11, 2022
• Expiry date: Jun 23, 2038

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to dendritic cells, the NFκB signaling pathway of which has been manipulated by RNA transfection, to the manufacture thereof and to use thereof.